nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolterodine—CHRM5—eye—autistic disorder	0.0133	0.0521	CbGeAlD
Tolterodine—CHRM4—head—autistic disorder	0.00968	0.0379	CbGeAlD
Tolterodine—CHRM4—nervous system—autistic disorder	0.00918	0.0359	CbGeAlD
Tolterodine—CHRM2—forebrain—autistic disorder	0.00907	0.0355	CbGeAlD
Tolterodine—CHRM4—central nervous system—autistic disorder	0.00884	0.0346	CbGeAlD
Tolterodine—CHRM2—telencephalon—autistic disorder	0.00834	0.0326	CbGeAlD
Tolterodine—CHRM1—forebrain—autistic disorder	0.00826	0.0323	CbGeAlD
Tolterodine—CHRM1—telencephalon—autistic disorder	0.00759	0.0297	CbGeAlD
Tolterodine—CHRM5—head—autistic disorder	0.00757	0.0296	CbGeAlD
Tolterodine—CHRM3—forebrain—autistic disorder	0.00739	0.0289	CbGeAlD
Tolterodine—CYP2D6—hindbrain—autistic disorder	0.00723	0.0282	CbGeAlD
Tolterodine—CHRM5—nervous system—autistic disorder	0.00718	0.0281	CbGeAlD
Tolterodine—CHRM4—brain—autistic disorder	0.00702	0.0274	CbGeAlD
Tolterodine—CHRM5—central nervous system—autistic disorder	0.00691	0.027	CbGeAlD
Tolterodine—CHRM3—telencephalon—autistic disorder	0.0068	0.0266	CbGeAlD
Tolterodine—KCNH2—forebrain—autistic disorder	0.00655	0.0256	CbGeAlD
Tolterodine—KCNH2—telencephalon—autistic disorder	0.00603	0.0236	CbGeAlD
Tolterodine—CHRM5—brain—autistic disorder	0.00548	0.0214	CbGeAlD
Tolterodine—CHRM2—head—autistic disorder	0.0052	0.0203	CbGeAlD
Tolterodine—CHRM3—digestive system—autistic disorder	0.00519	0.0203	CbGeAlD
Tolterodine—CHRM2—nervous system—autistic disorder	0.00493	0.0193	CbGeAlD
Tolterodine—CYP2C19—digestive system—autistic disorder	0.00482	0.0189	CbGeAlD
Tolterodine—CHRM2—central nervous system—autistic disorder	0.00474	0.0185	CbGeAlD
Tolterodine—CHRM1—head—autistic disorder	0.00473	0.0185	CbGeAlD
Tolterodine—CHRM1—nervous system—autistic disorder	0.00448	0.0175	CbGeAlD
Tolterodine—Atomoxetine—HTR1D—autistic disorder	0.00439	0.279	CrCbGaD
Tolterodine—CHRM1—central nervous system—autistic disorder	0.00432	0.0169	CbGeAlD
Tolterodine—CHRM3—head—autistic disorder	0.00423	0.0165	CbGeAlD
Tolterodine—CYP2D6—brainstem—autistic disorder	0.00414	0.0162	CbGeAlD
Tolterodine—CHRM3—nervous system—autistic disorder	0.00401	0.0157	CbGeAlD
Tolterodine—CYP2D6—forebrain—autistic disorder	0.004	0.0156	CbGeAlD
Tolterodine—CHRM3—central nervous system—autistic disorder	0.00386	0.0151	CbGeAlD
Tolterodine—CHRM2—brain—autistic disorder	0.00376	0.0147	CbGeAlD
Tolterodine—KCNH2—head—autistic disorder	0.00375	0.0147	CbGeAlD
Tolterodine—CYP2C9—digestive system—autistic disorder	0.00374	0.0146	CbGeAlD
Tolterodine—CYP2D6—telencephalon—autistic disorder	0.00367	0.0144	CbGeAlD
Tolterodine—KCNH2—nervous system—autistic disorder	0.00356	0.0139	CbGeAlD
Tolterodine—Labetalol—ADRB2—autistic disorder	0.00351	0.224	CrCbGaD
Tolterodine—CHRM1—brain—autistic disorder	0.00343	0.0134	CbGeAlD
Tolterodine—KCNH2—central nervous system—autistic disorder	0.00343	0.0134	CbGeAlD
Tolterodine—KCNH2—cerebellum—autistic disorder	0.00335	0.0131	CbGeAlD
Tolterodine—CHRM3—brain—autistic disorder	0.00307	0.012	CbGeAlD
Tolterodine—CYP3A4—digestive system—autistic disorder	0.00285	0.0111	CbGeAlD
Tolterodine—CYP2D6—digestive system—autistic disorder	0.00281	0.011	CbGeAlD
Tolterodine—KCNH2—brain—autistic disorder	0.00272	0.0106	CbGeAlD
Tolterodine—Atomoxetine—HTR1B—autistic disorder	0.0026	0.166	CrCbGaD
Tolterodine—CYP2D6—head—autistic disorder	0.00229	0.00895	CbGeAlD
Tolterodine—CYP3A4—nervous system—autistic disorder	0.0022	0.00862	CbGeAlD
Tolterodine—CYP2D6—nervous system—autistic disorder	0.00217	0.00848	CbGeAlD
Tolterodine—CYP3A4—central nervous system—autistic disorder	0.00212	0.0083	CbGeAlD
Tolterodine—Chlorphenamine—SLC6A4—autistic disorder	0.00209	0.133	CrCbGaD
Tolterodine—CYP2D6—central nervous system—autistic disorder	0.00209	0.00817	CbGeAlD
Tolterodine—CYP2D6—cerebellum—autistic disorder	0.00204	0.00798	CbGeAlD
Tolterodine—Atomoxetine—SLC6A4—autistic disorder	0.00176	0.112	CrCbGaD
Tolterodine—CYP2D6—brain—autistic disorder	0.00166	0.00648	CbGeAlD
Tolterodine—Atomoxetine—HTR2A—autistic disorder	0.00135	0.086	CrCbGaD
Tolterodine—CHRM3—GPCR downstream signaling—PIK3CG—autistic disorder	8.73e-05	0.00012	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—DRD3—autistic disorder	8.73e-05	0.00012	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—SLC25A12—autistic disorder	8.71e-05	0.00012	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—DPYD—autistic disorder	8.71e-05	0.00012	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—MAOB—autistic disorder	8.68e-05	0.000119	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—IL5—autistic disorder	8.66e-05	0.000119	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—PIK3CG—autistic disorder	8.65e-05	0.000119	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—IL5—autistic disorder	8.63e-05	0.000118	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CALCA—autistic disorder	8.55e-05	0.000117	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—IL5—autistic disorder	8.55e-05	0.000117	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CALCA—autistic disorder	8.52e-05	0.000117	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—ITGB3—autistic disorder	8.52e-05	0.000117	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—SLC19A1—autistic disorder	8.48e-05	0.000116	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CALCA—autistic disorder	8.44e-05	0.000116	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—POMC—autistic disorder	8.34e-05	0.000114	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—PRKCB—autistic disorder	8.31e-05	0.000114	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—POMC—autistic disorder	8.31e-05	0.000114	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—HTR2A—autistic disorder	8.31e-05	0.000114	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—IL2—autistic disorder	8.3e-05	0.000114	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—PRKCB—autistic disorder	8.29e-05	0.000114	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—autistic disorder	8.26e-05	0.000113	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—COMT—autistic disorder	8.25e-05	0.000113	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—POMC—autistic disorder	8.23e-05	0.000113	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—GSTP1—autistic disorder	8.21e-05	0.000113	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—PRKCB—autistic disorder	8.21e-05	0.000113	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—MAOA—autistic disorder	8.19e-05	0.000112	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	8.18e-05	0.000112	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—TPH2—autistic disorder	8.14e-05	0.000112	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—CACNA1C—autistic disorder	8.1e-05	0.000111	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—TPH2—autistic disorder	8.07e-05	0.000111	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—DPYD—autistic disorder	8.01e-05	0.00011	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—CAT—autistic disorder	7.99e-05	0.00011	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—PIK3CG—autistic disorder	7.96e-05	0.000109	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—HTR2A—autistic disorder	7.96e-05	0.000109	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—IL2—autistic disorder	7.95e-05	0.000109	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—DPYD—autistic disorder	7.94e-05	0.000109	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—PIK3CG—autistic disorder	7.93e-05	0.000109	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—TSC2—autistic disorder	7.89e-05	0.000108	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—PIK3CG—autistic disorder	7.85e-05	0.000108	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—autistic disorder	7.79e-05	0.000107	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—LEP—autistic disorder	7.72e-05	0.000106	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—APOE—autistic disorder	7.72e-05	0.000106	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—POMC—autistic disorder	7.57e-05	0.000104	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—TSC2—autistic disorder	7.56e-05	0.000104	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—ADSL—autistic disorder	7.56e-05	0.000104	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—PRL—autistic disorder	7.55e-05	0.000104	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—POMC—autistic disorder	7.55e-05	0.000104	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—GSTM1—autistic disorder	7.55e-05	0.000104	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—PLA2G4A—autistic disorder	7.55e-05	0.000104	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—PRL—autistic disorder	7.53e-05	0.000103	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—POMC—autistic disorder	7.48e-05	0.000103	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	7.46e-05	0.000102	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—PRL—autistic disorder	7.46e-05	0.000102	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—CACNA1C—autistic disorder	7.45e-05	0.000102	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—XDH—autistic disorder	7.41e-05	0.000102	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—LEP—autistic disorder	7.4e-05	0.000102	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—APOE—autistic disorder	7.4e-05	0.000102	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—CACNA1C—autistic disorder	7.38e-05	0.000101	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—DHFR—autistic disorder	7.37e-05	0.000101	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—PRKCB—autistic disorder	7.28e-05	0.0001	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—NPAS2—autistic disorder	7.27e-05	9.98e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—STX1A—autistic disorder	7.27e-05	9.98e-05	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—GPX1—autistic disorder	7.23e-05	9.92e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—ADRB2—autistic disorder	7.17e-05	9.84e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—ADRB2—autistic disorder	7.14e-05	9.81e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—autistic disorder	7.1e-05	9.74e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—ADRB2—autistic disorder	7.07e-05	9.71e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—TCN2—autistic disorder	7.02e-05	9.64e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—PRKCB—autistic disorder	6.98e-05	9.57e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—APC—autistic disorder	6.97e-05	9.57e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—PIK3CG—autistic disorder	6.97e-05	9.57e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—EGF—autistic disorder	6.89e-05	9.46e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—DHFR—autistic disorder	6.78e-05	9.3e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—AVP—autistic disorder	6.73e-05	9.24e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—DHFR—autistic disorder	6.72e-05	9.22e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—AVP—autistic disorder	6.71e-05	9.21e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—IGF2—autistic disorder	6.7e-05	9.2e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—ADA—autistic disorder	6.7e-05	9.2e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—IGF2—autistic disorder	6.68e-05	9.17e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—APC—autistic disorder	6.68e-05	9.16e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—PIK3CG—autistic disorder	6.68e-05	9.16e-05	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—MTHFR—autistic disorder	6.67e-05	9.15e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—AVP—autistic disorder	6.65e-05	9.12e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—POMC—autistic disorder	6.64e-05	9.11e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—IGF2—autistic disorder	6.62e-05	9.08e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—EGF—autistic disorder	6.6e-05	9.06e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—IGF1—autistic disorder	6.38e-05	8.76e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—POMC—autistic disorder	6.35e-05	8.72e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—MAPK1—autistic disorder	6.35e-05	8.72e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—PLA2G4A—autistic disorder	6.33e-05	8.69e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—PLA2G4A—autistic disorder	6.31e-05	8.66e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—PLA2G4A—autistic disorder	6.25e-05	8.58e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	6.21e-05	8.52e-05	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—APOE—autistic disorder	6.21e-05	8.52e-05	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—IL2—autistic disorder	6.17e-05	8.46e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—MEF2C—autistic disorder	6.16e-05	8.45e-05	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—IL2—autistic disorder	6.15e-05	8.44e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—MEF2C—autistic disorder	6.14e-05	8.43e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—IGF1—autistic disorder	6.11e-05	8.39e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—RORA—autistic disorder	6.11e-05	8.39e-05	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—IL2—autistic disorder	6.09e-05	8.35e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—MAPK1—autistic disorder	6.08e-05	8.35e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—MEF2C—autistic disorder	6.08e-05	8.34e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—SERPINE1—autistic disorder	6.06e-05	8.32e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—ITGB3—autistic disorder	6e-05	8.24e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—ITGB3—autistic disorder	5.98e-05	8.21e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—ITGB3—autistic disorder	5.92e-05	8.13e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—SERPINE1—autistic disorder	5.8e-05	7.97e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—CYP19A1—autistic disorder	5.77e-05	7.92e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—MAOB—autistic disorder	5.73e-05	7.86e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	5.66e-05	7.77e-05	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—PIK3CG—autistic disorder	5.6e-05	7.69e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—HTR2A—autistic disorder	5.6e-05	7.69e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—IL2—autistic disorder	5.6e-05	7.69e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—HTR2A—autistic disorder	5.58e-05	7.67e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—IL2—autistic disorder	5.58e-05	7.66e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—HTR2A—autistic disorder	5.53e-05	7.59e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—IL2—autistic disorder	5.53e-05	7.59e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	5.42e-05	7.43e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—COMT—autistic disorder	5.36e-05	7.36e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—GSTP1—autistic disorder	5.34e-05	7.33e-05	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—POMC—autistic disorder	5.33e-05	7.32e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—MAOA—autistic disorder	5.33e-05	7.31e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—TPH2—autistic disorder	5.32e-05	7.31e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—TSC2—autistic disorder	5.32e-05	7.31e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—CYP19A1—autistic disorder	5.31e-05	7.28e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—TSC2—autistic disorder	5.3e-05	7.28e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—CYP19A1—autistic disorder	5.26e-05	7.22e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—TSC2—autistic disorder	5.25e-05	7.21e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—DPYD—autistic disorder	5.24e-05	7.19e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—APOE—autistic disorder	5.21e-05	7.15e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—LEP—autistic disorder	5.21e-05	7.15e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—CAT—autistic disorder	5.19e-05	7.13e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—LEP—autistic disorder	5.19e-05	7.13e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—APOE—autistic disorder	5.19e-05	7.13e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—LEP—autistic disorder	5.14e-05	7.06e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—APOE—autistic disorder	5.14e-05	7.06e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—HRAS—autistic disorder	5.1e-05	7e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	4.94e-05	6.78e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—COMT—autistic disorder	4.93e-05	6.77e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—PRKCB—autistic disorder	4.91e-05	6.74e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—GSTP1—autistic disorder	4.91e-05	6.74e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—GSTM1—autistic disorder	4.91e-05	6.73e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—PLA2G4A—autistic disorder	4.91e-05	6.73e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—IL2—autistic disorder	4.91e-05	6.73e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—MAOA—autistic disorder	4.9e-05	6.72e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—PRKCB—autistic disorder	4.9e-05	6.72e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—COMT—autistic disorder	4.89e-05	6.71e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—HRAS—autistic disorder	4.88e-05	6.7e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—IL6—autistic disorder	4.88e-05	6.7e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CACNA1C—autistic disorder	4.87e-05	6.68e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—GSTP1—autistic disorder	4.87e-05	6.68e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—MAOA—autistic disorder	4.86e-05	6.67e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—PRKCB—autistic disorder	4.85e-05	6.66e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—CAT—autistic disorder	4.78e-05	6.56e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—CAT—autistic disorder	4.74e-05	6.5e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—PIK3CG—autistic disorder	4.7e-05	6.45e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—APC—autistic disorder	4.7e-05	6.45e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—GPX1—autistic disorder	4.7e-05	6.45e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—IL2—autistic disorder	4.7e-05	6.45e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—PIK3CG—autistic disorder	4.69e-05	6.43e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—APC—autistic disorder	4.69e-05	6.43e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—IL6—autistic disorder	4.67e-05	6.42e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—EGF—autistic disorder	4.65e-05	6.38e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—APC—autistic disorder	4.64e-05	6.37e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—PIK3CG—autistic disorder	4.64e-05	6.37e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—EGF—autistic disorder	4.63e-05	6.36e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—PTEN—autistic disorder	4.62e-05	6.34e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—EGF—autistic disorder	4.59e-05	6.3e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PLA2G4A—autistic disorder	4.51e-05	6.19e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—GSTM1—autistic disorder	4.51e-05	6.19e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—POMC—autistic disorder	4.47e-05	6.14e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—GSTM1—autistic disorder	4.47e-05	6.14e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PLA2G4A—autistic disorder	4.47e-05	6.14e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—POMC—autistic disorder	4.46e-05	6.12e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—DHFR—autistic disorder	4.43e-05	6.08e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—PTEN—autistic disorder	4.42e-05	6.07e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—POMC—autistic disorder	4.42e-05	6.06e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—MTHFR—autistic disorder	4.34e-05	5.95e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—GPX1—autistic disorder	4.32e-05	5.93e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—IGF1—autistic disorder	4.3e-05	5.91e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—IGF1—autistic disorder	4.29e-05	5.89e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—GPX1—autistic disorder	4.28e-05	5.88e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—MAPK1—autistic disorder	4.28e-05	5.88e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—MAPK1—autistic disorder	4.27e-05	5.86e-05	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—PTGS2—autistic disorder	4.25e-05	5.84e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—IGF1—autistic disorder	4.25e-05	5.83e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—MAPK1—autistic disorder	4.23e-05	5.8e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—SERPINE1—autistic disorder	4.09e-05	5.61e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—SERPINE1—autistic disorder	4.07e-05	5.59e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—APOE—autistic disorder	4.04e-05	5.54e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—SERPINE1—autistic disorder	4.03e-05	5.54e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—MTHFR—autistic disorder	3.99e-05	5.47e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—MTHFR—autistic disorder	3.95e-05	5.43e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—MAPK1—autistic disorder	3.75e-05	5.15e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—APOE—autistic disorder	3.71e-05	5.1e-05	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—PTEN—autistic disorder	3.71e-05	5.09e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—APOE—autistic disorder	3.68e-05	5.05e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—PIK3CG—autistic disorder	3.64e-05	5e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—MAPK1—autistic disorder	3.59e-05	4.93e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CYP19A1—autistic disorder	3.47e-05	4.76e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—POMC—autistic disorder	3.47e-05	4.76e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—HRAS—autistic disorder	3.44e-05	4.72e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—HRAS—autistic disorder	3.43e-05	4.7e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—HRAS—autistic disorder	3.39e-05	4.66e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PIK3CG—autistic disorder	3.35e-05	4.6e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PIK3CG—autistic disorder	3.32e-05	4.56e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—IL2—autistic disorder	3.31e-05	4.54e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—IL2—autistic disorder	3.3e-05	4.53e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—IL6—autistic disorder	3.29e-05	4.52e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—IL6—autistic disorder	3.28e-05	4.5e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—IL2—autistic disorder	3.26e-05	4.48e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—IL6—autistic disorder	3.25e-05	4.46e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—COMT—autistic disorder	3.23e-05	4.43e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—GSTP1—autistic disorder	3.21e-05	4.41e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—MAOA—autistic disorder	3.2e-05	4.4e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—POMC—autistic disorder	3.19e-05	4.38e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—POMC—autistic disorder	3.16e-05	4.34e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CAT—autistic disorder	3.12e-05	4.29e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—PTEN—autistic disorder	3.11e-05	4.27e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—PTEN—autistic disorder	3.1e-05	4.26e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—PTEN—autistic disorder	3.07e-05	4.22e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—HRAS—autistic disorder	3.01e-05	4.14e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PLA2G4A—autistic disorder	2.95e-05	4.05e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—GSTM1—autistic disorder	2.95e-05	4.05e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—HRAS—autistic disorder	2.88e-05	3.96e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—IL6—autistic disorder	2.88e-05	3.96e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—GPX1—autistic disorder	2.82e-05	3.88e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—PTGS2—autistic disorder	2.77e-05	3.8e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—IL6—autistic disorder	2.76e-05	3.79e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—MTHFR—autistic disorder	2.61e-05	3.58e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PTGS2—autistic disorder	2.54e-05	3.49e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—MAPK1—autistic disorder	2.53e-05	3.47e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—MAPK1—autistic disorder	2.52e-05	3.46e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PTGS2—autistic disorder	2.52e-05	3.46e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—MAPK1—autistic disorder	2.5e-05	3.43e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—APOE—autistic disorder	2.43e-05	3.33e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—PTEN—autistic disorder	2.41e-05	3.31e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PTEN—autistic disorder	2.22e-05	3.05e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PTEN—autistic disorder	2.2e-05	3.02e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PIK3CG—autistic disorder	2.19e-05	3.01e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—POMC—autistic disorder	2.08e-05	2.86e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—HRAS—autistic disorder	2.03e-05	2.79e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—HRAS—autistic disorder	2.02e-05	2.78e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—HRAS—autistic disorder	2.01e-05	2.75e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—IL6—autistic disorder	1.94e-05	2.67e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—IL6—autistic disorder	1.94e-05	2.66e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—IL6—autistic disorder	1.92e-05	2.63e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PTGS2—autistic disorder	1.66e-05	2.28e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PTEN—autistic disorder	1.45e-05	1.99e-05	CbGpPWpGaD
